Novartis reported $27.65B in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 12618M 268M
Astrazeneca AZN:US $ 21815M 925M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Biogen BIIB:US $ 5018M 1071.4M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Canopy Growth Corp WEED:CN C$ 404.41M 191.51M
Catalent CTLT:US $ 1072M 26M
Corcept Therapeutics CORT:US $ 49.06M 8.19M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Endo International Ordinary Shares ENDP:US $ 1181.67M 194.47M
Gilead Sciences GILD:US $ 9220M 662M
Glaxosmithkline GSK:US $ 37835M 13557M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Horizon Pharma HZNP:US $ 791.06M 34.12M
JAZZ PHA JAZZ:US $ 705.44M 31.97M
Lannett LCI:US $ 104.94M 10.58M
Novartis NOVN:VX SF 27646M 2161M
Pacira Pharmaceuticals PCRX:US $ 133.18M 171.89M
Perrigo Ordinary Shares PRGO:US $ 1014.6M 33.3M
Phibro Animal Health PAHC:US $ 190.83M 3.73M
Prestige Brands PBH:US $ 155.35M 11.93M
Supernus Pharmaceuticals SUPN:US $ 735.54M 450.98M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M
Valeant Pharmaceuticals VRX:CN $ 6432.14M 1658.14M
Zoetis ZTS:US $ 3051M 17M